Logo image of MEGI

NYLI CBRE GBL INFR MGA TRM F (MEGI) Stock Price, Quote, News and Overview

NYSE:MEGI - New York Stock Exchange, Inc. - US56064Q1076 - Currency: USD

12.65  +0.08 (+0.64%)

After market: 12.48 -0.17 (-1.34%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MEGI. MEGI was compared to 0 industry peers in the Unkown industry. MEGI may be in some trouble as it scores bad on both profitability and health. MEGI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MEGI has reported negative net income.
MEGI Yearly Net Income VS EBIT VS OCF VS FCFMEGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA -16.4%
ROE -22.44%
ROIC 5.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MEGI Yearly ROA, ROE, ROICMEGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 -5 -10 -15 -20

1.3 Margins

Industry RankSector Rank
OM 71.17%
PM (TTM) N/A
GM 71.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEGI Yearly Profit, Operating, Gross MarginsMEGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 100 -100

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for MEGI remains at a similar level compared to 1 year ago.
MEGI has a better debt/assets ratio than last year.
MEGI Yearly Shares OutstandingMEGI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M 40M 50M
MEGI Yearly Total Debt VS Total AssetsMEGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that MEGI is in the distress zone and has some risk of bankruptcy.
MEGI has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACCN/A
MEGI Yearly LT Debt VS Equity VS FCFMEGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 500M -500M 1B -1B

2.3 Liquidity

MEGI has a Current Ratio of 0.03. This is a bad value and indicates that MEGI is not financially healthy enough and could expect problems in meeting its short term obligations.
MEGI has a Quick Ratio of 0.03. This is a bad value and indicates that MEGI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
MEGI Yearly Current Assets VS Current LiabilitesMEGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100M 200M 300M 400M

More info and screens

1

3. Growth

3.1 Past

MEGI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -366.94%.
MEGI shows a strong growth in Revenue. In the last year, the Revenue has grown by 99.77%.
EPS 1Y (TTM)-366.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.31%
Revenue 1Y (TTM)99.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-20.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEGI Yearly Revenue VS EstimatesMEGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 20M 40M 60M 80M
MEGI Yearly EPS VS EstimatesMEGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MEGI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEGI Price Earnings VS Forward Price EarningsMEGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MEGI Per share dataMEGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.87%, MEGI is a good candidate for dividend investing.
MEGI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.87%

5.2 History

MEGI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MEGI Yearly Dividends per shareMEGI Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

MEGI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-19.63%
EPS Next 2YN/A
EPS Next 3YN/A
MEGI Yearly Income VS Free CF VS DividendMEGI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 0 -500M -1B

More info and screens

NYLI CBRE GBL INFR MGA TRM F

NYSE:MEGI (2/21/2025, 8:04:01 PM)

After market: 12.48 -0.17 (-1.34%)

12.65

+0.08 (+0.64%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners48.35%
Inst Owner Change-71.78%
Ins Owners0.08%
Ins Owner Change0.38%
Market Cap658.43M
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 10.87%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-19.63%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-24 2025-02-24 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.86
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-3.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.84
BVpS14.75
TBVpS14.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.4%
ROE -22.44%
ROCE 8.9%
ROIC 5.17%
ROICexc 5.17%
ROICexgc 5.17%
OM 71.17%
PM (TTM) N/A
GM 71.51%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.03
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-366.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)99.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-20.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.37%
OCF growth 3YN/A
OCF growth 5YN/A